Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global blood glucose monitoring devices market. The report provides market landscape, competitive landscape and market trends information on the blood glucose monitoring devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the blood glucose monitoring devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd, LifeScan, Inc., Bayer HealthCare AG and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the blood glucose monitoring devices globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the blood glucose monitoring devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global blood glucose monitoring devices market and the factors shaping it.

Table Of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Disease Overview - Diabetes 8
3.1 Types of Diabetes 8
3.1.1 Type 1 Diabetes 8
3.1.2 Type 2 Diabetes 8
3.1.3 Gestational Diabetes 8
3.2 Signs and Symptoms 8
3.3 Diagnosis 9
3.3.1 Fasting Plasma Glucose (FPG) Test 9
3.3.2 Oral Glucose Tolerance Test (OGTT) 9
3.3.3 Random Plasma Glucose Test 9
3.4 Epidemiology 10
3.4.1 Prevalence of Diabetes in the US 10
3.4.2 Prevalence of Diabetes in the UK 10
3.4.3 Prevalence of Diabetes in Japan 10
3.4.4 Prevalence of Diabetes in India 10
3.4.5 Prevalence of Diabetes in China 10
4 Device Overview - Blood Glucose Monitoring Devices 11
4.1 Traditional Glucose Meters 11
4.2 Blood Glucose Test Strips 11
4.3 Lancets 11
5 Blood Glucose Monitoring Devices - Global Market Characterization 12
5.1 Blood Glucose Monitoring Devices Market, Global, Revenue ($m), Historic, 2003-2010 12
5.2 Blood Glucose Monitoring Devices Market, Global, Revenue ($m), Forecast, 2010-2017 14
5.3 Blood Glucose Monitoring Devices Market Trends 15
5.3.1 Co-marketing of Blood Glucose Meters with Insulin Pumps to Provide an Overall Diabetes Management Solution 15
5.4 Blood Glucose Monitoring Devices, Market Dynamics 16
5.4.1 Market Drivers 16
5.4.2 Market Restraints 21
6 Blood Glucose Monitoring Devices Market, Analysis by Country, Revenue ($m), 2003-2017 24
6.1 Blood Glucose Monitoring Devices Market, the US, Revenue ($m), Historic, 2003-2010 24
6.2 Blood Glucose Monitoring Devices Market, the US, Revenue ($m), Forecast, 2010-2017 26
6.3 Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), Historic, 2003-2010 27
6.4 Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), Forecast, 2010-2017 28
6.5 Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), Historic, 2003-2010 29
6.6 Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), Forecast, 2010-2017 30
6.7 Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), Historic, 2003-2010 31
6.8 Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), Forecast, 2010-2017 32
6.9 Blood Glucose Monitoring Devices Market, France, Revenue ($m), Historic, 2003-2010 33
6.10 Blood Glucose Monitoring Devices Market, France, Revenue ($m), Forecast, 2010-2017 34
6.11 Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), Historic, 2003-2010 35
6.12 Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), Forecast, 2010-2017 36
6.13 Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), Historic, 2003-2010 37
6.14 Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), Forecast, 2010-2017 38
6.15 Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), Historic, 2003-2010 39
6.16 Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), Forecast, 2010-2017 40
6.17 Blood Glucose Monitoring Devices Market, China, Revenue ($m), Historic, 2003-2010 41
6.18 Blood Glucose Monitoring Devices Market, China, Revenue ($m), Forecast, 2010-2017 42
6.19 Blood Glucose Monitoring Devices Market, India, Revenue ($m), Historic, 2003-2010 43
6.20 Blood Glucose Monitoring Devices Market, India, Revenue ($m), Forecast, 2010-2017 44
6.21 Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), Historic, 2003-2010 45
6.22 Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), Forecast 2010-2017 46
6.23 Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), Historic, 2003-2010 47
6.24 Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), Forecast, 2010-2017 48
7 Blood Glucose Monitoring Devices Market: Strategic Competitive Assessment 49
7.1 Blood Glucose Monitoring Devices Market, Company Share (%), Global, 2010 49
7.2 Blood Glucose Monitoring Devices Market, Key Player Profiles 50
7.2.1 F. Hoffmann-La Roche Ltd. (Roche) 50
7.2.2 LifeScan, Inc. (LifeScan) 55
7.2.3 Bayer Healthcare AG (Bayer Healthcare) 60
7.2.4 Abbott Laboratories (Abbott) 64
8 Blood Glucose Monitoring Devices Market: Key Marketed Products 68
8.1 Accu-Chek Aviva 68
8.1.1 Product Description 68
8.1.2 Features and Benefits 68
8.2 Accu-Chek Active System 69
8.2.1 Product Description 69
8.2.2 Features and Benefits 69
8.3 Accu-Chek Aviva Nano 69
8.3.1 Product Description 69
8.3.2 Features and Benefits 69
8.4 OneTouch Basic 69
8.4.1 Product Description 69
8.4.2 Features and Benefits 69
8.5 OneTouch Ultra 69
8.5.1 Product Description 69
8.5.2 Features and Benefits 70
8.6 OneTouch UltraMini 70
8.6.1 Product Description 70
8.6.2 Features and Benefits 70
8.7 OneTouch UltraSmart 70
8.7.1 Product Description 70
8.7.2 Features and Benefits 70
8.8 Bayer’s CONTOUR Meter 71
8.8.1 Product Description 71
8.8.2 Features and Benefits 71
8.9 Bayer BREEZE 2 Meter 71
8.9.1 Product Description 71
8.9.2 Features and Benefits 71
8.10 Bayer DIDGET Meter 71
8.10.1 Product Description 71
8.10.2 Features and Benefits 71
9 Blood Glucose Monitoring Devices Market - Strategic Pipeline Assessment 72
9.1 Blood Glucose Monitoring Devices Market, Pipeline Assessment, by Development Stage 72
9.2 Profile of Promising Products under Clinical Development 74
9.2.1 GlucoTrack 74
9.2.2 Glucoband 76
9.2.3 Breath Based Blood Glucose Meter 76
9.2.4 Optimus 77
9.2.5 I-SugarX 77
10 Blood Glucose Monitoring Devices Market - Deals Landscape 78
10.1 Blood Glucose Monitoring Devices Market, Deals Overview 78
10.2 Blood Glucose Monitoring Devices Key Deals (2011) 78
10.2.1 Bayer HealthCare Diabetes Care Expands Partnership with Medtronic 78
10.2.2 PositiveID Enters into Agreement with HMD BioMedical 79
10.2.3 Powder Pharmaceuticals Enters into an Agreement with Health-Chem Diagnostics 79
10.2.4 Perrigo Enters into Distribution Agreement with AgaMatrix 79
10.2.5 EyeSense Enters into an Agreement with QIAGEN 80
11 Appendix 81
11.1 Market Definitions 81
11.1.1 Blood Glucose Meters 81
11.1.2 Traditional Glucose Meters 81
11.1.3 Blood Glucose Test Strips 81
11.1.4 Lancets 82
11.2 Abbreviations (in alphabetical order) 82
11.3 Sources (in alphabetical order) 83
11.4 Research Methodology 83
11.4.1 Secondary Research 83
11.4.2 Primary Research 84
11.4.3 Models 84
11.4.4 Forecasts 84
11.4.5 Expert Panel 85
11.5 GlobalData Consulting 85
11.6 Contact Us 85
11.7 Disclaimer 85

List of Tables

Table 1: Fasting Plasma Glucose Test 9
Table 2: Oral Glucose Tolerance Test 9
Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 9
Table 4: Blood Glucose Monitoring Devices Market, Global, Revenue ($m), 2003-2010 12
Table 5: Blood Glucose Monitoring Devices Market, Global, Revenue ($m), 2010-2017 14
Table 6: Diabetes Prevalence (%) and Patient Population, by Country, 2011 17
Table 7: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 18
Table 8: New Technologies in Glucose Monitoring 21
Table 9: Risks of Blood Borne Diseases due to Improper Use of Glucose Monitoring Equipment 22
Table 10: Blood Glucose Monitoring Devices Market, the US, Revenue ($m), 2003-2010 24
Table 11: Blood Glucose Monitoring Devices Market, the US, Revenue ($m), 2010-2017 26
Table 12: Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), 2003-2010 27
Table 13: Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), 2010-2017 28
Table 14: Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), 2003-2010 29
Table 15: Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), 2010-2017 30
Table 16: Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), 2003-2010 31
Table 17: Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), 2010-2017 32
Table 18: Blood Glucose Monitoring Devices Market, France, Revenue ($m), 2003-2010 33
Table 19: Blood Glucose Monitoring Devices Market, France, Revenue ($m), 2010-2017 34
Table 20: Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), 2003-2010 35
Table 21: Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), 2010-2017 36
Table 22: Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), 2003-2010 37
Table 23: Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), 2010-2017 38
Table 24: Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), 2003-2010 39
Table 25: Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), 2010-2017 40
Table 26: Blood Glucose Monitoring Devices Market, China, Revenue ($m), 2003-2010 41
Table 27: Blood Glucose Monitoring Devices Market, China, Revenue ($m), 2010-2017 42
Table 28: Blood Glucose Monitoring Devices Market, India, Revenue ($m), 2003-2010 43
Table 29: Blood Glucose Monitoring Devices Market, India, Revenue ($m), 2010-2017 44
Table 30: Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), 2003-2010 45
Table 31: Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), 2010-2017 46
Table 32: Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003-2010 47
Table 33: Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010-2017 48
Table 34: Blood Glucose Monitoring Devices Market, Global, Company Revenue ($m), 2010 49
Table 35: F. Hoffmann-La Roche Ltd., Key Marketed Products 50
Table 36: F. Hoffmann-La Roche Ltd., Key Pipeline Products 51
Table 37: LifeScan, Inc., Key Marketed Products 56
Table 38: LifeScan, Inc., Key Pipeline Products 57
Table 39: Bayer Healthcare AG, Key Marketed Products 61
Table 40: Abbott Laboratories, Key Marketed Products 64
Table 41: Blood Glucose Monitoring Devices, Pipeline Assessment by Development Stage, 2010 72
Table 42: Blood Glucose Monitoring Devices, Pipeline Products, 2010 73
Table 43: Product Status, GlucoTrack 74
Table 44: Clinical Trial 1, GlucoTrack 74
Table 45: Clinical Trial 2, GlucoTrack 75
Table 46: Clinical Trial 3, GlucoTrack 75
Table 47: Product Status, Glucoband 76
Table 48: Product Status, Breath Based Blood Glucose Meter 76
Table 49: Product Status, Optimus 77
Table 50: Product Status, I-SugarX 77

List of Figures

Figure 1: Blood Glucose Monitoring Devices Market, Global, Revenue ($m), 2003-2010 12
Figure 2: Blood Glucose Monitoring Devices Market, Global, Revenue ($m), 2010-2017 14
Figure 3: Blood Glucose Monitoring Devices, Market Dynamics 16
Figure 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011* 16
Figure 5: Healthcare Expenditure on Diabetes, 2007-2010 19
Figure 6: Blood Glucose Monitoring Devices Market, the US, Revenue ($m), 2003-2010 24
Figure 7: Blood Glucose Monitoring Devices Market, the US, Revenue ($m), 2010-2017 26
Figure 8: Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), 2003-2010 27
Figure 9: Blood Glucose Monitoring Devices Market, Canada, Revenue ($m), 2010-2017 28
Figure 10: Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), 2003-2010 29
Figure 11: Blood Glucose Monitoring Devices Market, the UK, Revenue ($m), 2010-2017 30
Figure 12: Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), 2003-2010 31
Figure 13: Blood Glucose Monitoring Devices Market, Germany, Revenue ($m), 2010-2017 32
Figure 14: Blood Glucose Monitoring Devices Market, France, Revenue ($m), 2003-2010 33
Figure 15: Blood Glucose Monitoring Devices Market, France, Revenue ($m), 2010-2017 34
Figure 16: Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), 2003-2010 35
Figure 17: Blood Glucose Monitoring Devices Market, Italy, Revenue ($m), 2010-2017 36
Figure 18: Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), 2003-2010 37
Figure 19: Blood Glucose Monitoring Devices Market, Spain, Revenue ($m), 2010-2017 38
Figure 20: Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), 2003-2010 39
Figure 21: Blood Glucose Monitoring Devices Market, Japan, Revenue ($m), 2010-2017 40
Figure 22: Blood Glucose Monitoring Devices Market, China, Revenue ($m), 2003-2010 41
Figure 23: Blood Glucose Monitoring Devices Market, China, Revenue ($m), 2010-2017 42
Figure 24: Blood Glucose Monitoring Devices Market, India, Revenue ($m), 2003-2010 43
Figure 25: Blood Glucose Monitoring Devices Market, India, Revenue ($m), 2010-2017 44
Figure 26: Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), 2003-2010 45
Figure 27: Blood Glucose Monitoring Devices Market, Australia, Revenue ($m), 2010-2017 46
Figure 28: Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2003-2010 47
Figure 29: Blood Glucose Monitoring Devices Market, Brazil, Revenue ($m), 2010-2017 48
Figure 30: Blood Glucose Monitoring Devices Market, Global, Company Share (%), 2010 49
Figure 31: F. Hoffmann-La. Roche, SWOT Analysis 52
Figure 32: LifeScan Inc., SWOT Analysis 57
Figure 33: Bayer Healthcare, SWOT Analysis 61
Figure 34: Abbott Laboratories, SWOT Analysis 65
Figure 35: Blood Glucose Monitoring Devices Market, Key Marketed Products, 2010 68
Figure 36: Blood Glucose Monitoring Devices, Pipeline Assessment by Development Stage, 2010 72
Figure 37: Blood Glucose Monitoring Devices Market, Deals Overview, 2011 78

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.